Cargando…
Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3
Adaptor protein-2 (AP2), a central component of clathrin-coated vesicles (CCVs), is pivotal in clathrin-mediated endocytosis which internalises plasma membrane constituents such as G protein-coupled receptors (GPCRs)(1-3) . AP2, a heterotetramer of alpha, beta, mu and sigma subunits, links clathrin...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605788/ https://www.ncbi.nlm.nih.gov/pubmed/23222959 http://dx.doi.org/10.1038/ng.2492 |
_version_ | 1782263929623281664 |
---|---|
author | Nesbit, M. Andrew Hannan, Fadil M. Howles, Sarah A. Reed, Anita A.C. Cranston, Treena Thakker, Clare E. Gregory, Lorna Rimmer, Andrew J. Rust, Nigel Graham, Una Morrison, Patrick J. Hunter, Steven J. Whyte, Michael P. McVean, Gil Buck, David Thakker, Rajesh V. |
author_facet | Nesbit, M. Andrew Hannan, Fadil M. Howles, Sarah A. Reed, Anita A.C. Cranston, Treena Thakker, Clare E. Gregory, Lorna Rimmer, Andrew J. Rust, Nigel Graham, Una Morrison, Patrick J. Hunter, Steven J. Whyte, Michael P. McVean, Gil Buck, David Thakker, Rajesh V. |
author_sort | Nesbit, M. Andrew |
collection | PubMed |
description | Adaptor protein-2 (AP2), a central component of clathrin-coated vesicles (CCVs), is pivotal in clathrin-mediated endocytosis which internalises plasma membrane constituents such as G protein-coupled receptors (GPCRs)(1-3) . AP2, a heterotetramer of alpha, beta, mu and sigma subunits, links clathrin to vesicle membranes and binds to tyrosine-based and dileucine-based motifs of membrane-associated cargo proteins(1,4). Here, we show that AP2 sigma subunit (AP2S1) missense mutations, which all involved the Arg15 residue (Arg15Cys, Arg15His and Arg15Leu) that forms key contacts with dileucine-based motifs of CCV cargo proteins(4), result in familial hypocalciuric hypercalcemia type 3 (FHH3), an extracellular-calcium homeostasis disorder affecting parathyroids, kidneys and bone(5-7) These AP2S1 mutations occurred in >20% of FHH patients without calcium-sensing GPCR (CaSR) mutations which cause FHH1(8-12). AP2S1 mutations decreased the sensitivity of CaSR-expressing cells to extracellular-calcium and reduced CaSR endocytosis, likely through a loss of interaction with a C-terminus CaSR dileucine-based motif whose disruption also decreased intracellular signalling. Thus, our results reveal a new role for AP2 in extracellular-calcium homeostasis. |
format | Online Article Text |
id | pubmed-3605788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
record_format | MEDLINE/PubMed |
spelling | pubmed-36057882013-07-01 Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3 Nesbit, M. Andrew Hannan, Fadil M. Howles, Sarah A. Reed, Anita A.C. Cranston, Treena Thakker, Clare E. Gregory, Lorna Rimmer, Andrew J. Rust, Nigel Graham, Una Morrison, Patrick J. Hunter, Steven J. Whyte, Michael P. McVean, Gil Buck, David Thakker, Rajesh V. Nat Genet Article Adaptor protein-2 (AP2), a central component of clathrin-coated vesicles (CCVs), is pivotal in clathrin-mediated endocytosis which internalises plasma membrane constituents such as G protein-coupled receptors (GPCRs)(1-3) . AP2, a heterotetramer of alpha, beta, mu and sigma subunits, links clathrin to vesicle membranes and binds to tyrosine-based and dileucine-based motifs of membrane-associated cargo proteins(1,4). Here, we show that AP2 sigma subunit (AP2S1) missense mutations, which all involved the Arg15 residue (Arg15Cys, Arg15His and Arg15Leu) that forms key contacts with dileucine-based motifs of CCV cargo proteins(4), result in familial hypocalciuric hypercalcemia type 3 (FHH3), an extracellular-calcium homeostasis disorder affecting parathyroids, kidneys and bone(5-7) These AP2S1 mutations occurred in >20% of FHH patients without calcium-sensing GPCR (CaSR) mutations which cause FHH1(8-12). AP2S1 mutations decreased the sensitivity of CaSR-expressing cells to extracellular-calcium and reduced CaSR endocytosis, likely through a loss of interaction with a C-terminus CaSR dileucine-based motif whose disruption also decreased intracellular signalling. Thus, our results reveal a new role for AP2 in extracellular-calcium homeostasis. 2012-12-09 2013-01 /pmc/articles/PMC3605788/ /pubmed/23222959 http://dx.doi.org/10.1038/ng.2492 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Nesbit, M. Andrew Hannan, Fadil M. Howles, Sarah A. Reed, Anita A.C. Cranston, Treena Thakker, Clare E. Gregory, Lorna Rimmer, Andrew J. Rust, Nigel Graham, Una Morrison, Patrick J. Hunter, Steven J. Whyte, Michael P. McVean, Gil Buck, David Thakker, Rajesh V. Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3 |
title | Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3 |
title_full | Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3 |
title_fullStr | Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3 |
title_full_unstemmed | Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3 |
title_short | Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3 |
title_sort | mutations in ap2s1 cause familial hypocalciuric hypercalcemia type 3 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605788/ https://www.ncbi.nlm.nih.gov/pubmed/23222959 http://dx.doi.org/10.1038/ng.2492 |
work_keys_str_mv | AT nesbitmandrew mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT hannanfadilm mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT howlessaraha mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT reedanitaac mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT cranstontreena mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT thakkerclaree mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT gregorylorna mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT rimmerandrewj mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT rustnigel mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT grahamuna mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT morrisonpatrickj mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT hunterstevenj mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT whytemichaelp mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT mcveangil mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT buckdavid mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 AT thakkerrajeshv mutationsinap2s1causefamilialhypocalciurichypercalcemiatype3 |